Martine Mazzetti
Keine laufenden Positionen mehr
Profil
Martine Mazzetti is currently the Chief of Staff at VectivBio Holding AG.
Previously, she worked as the Global Head of IMED Project & Portfolio Management at AstraZeneca PLC from 2014 to 2017.
She also held the position of Global Head of Project Management Early Development at F.
Hoffmann-La Roche Ltd.
and Regulatory Head of Clinical Nutrition at Salvia BV.
Mazzetti earned a doctorate degree from Universität Saarbrücken.
Ehemalige bekannte Positionen von Martine Mazzetti
| Unternehmen | Position | Ende |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.11.2017 |
Salvia BV
 Salvia BV Miscellaneous Commercial ServicesCommercial Services Salvia BV is a Dutch private investment company founded and managed by Helmut Jeggle. The company was founded in 2018 and is based in Holzkirchen, Germany. The company invests in various areas such as life science, digital health, and deep tech, among others, mainly as a business angel, but also in later stages as a venture capitalist. Salvia has over 90 employees and has received over €71 million in funding from private investors and public entities. Salvia aims to assist innovative companies through its capital, expertise, and extensive network, with a focus on companies in the fields of deep tech and science that are driving sustainable change and can show the world the way forward. | Corporate Officer/Principal | - |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
| VECTIVBIO HOLDING AG | Personalreferent | - |
Ausbildung von Martine Mazzetti
| Universität Saarbrücken | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
VectivBio Holding AG
 VectivBio Holding AG Pharmaceuticals: MajorHealth Technology VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. It operates through Switzerland, Canada, and the United States geographical segment. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Salvia BV
Salvia BV Miscellaneous Commercial ServicesCommercial Services Salvia BV is a Dutch private investment company founded and managed by Helmut Jeggle. The company was founded in 2018 and is based in Holzkirchen, Germany. The company invests in various areas such as life science, digital health, and deep tech, among others, mainly as a business angel, but also in later stages as a venture capitalist. Salvia has over 90 employees and has received over €71 million in funding from private investors and public entities. Salvia aims to assist innovative companies through its capital, expertise, and extensive network, with a focus on companies in the fields of deep tech and science that are driving sustainable change and can show the world the way forward. | Commercial Services |
